Novo Holdings was advised by Morgan Stanley & Co. Legal advisory ... and Arnold was legal advisor to Novo Nordisk. "Novo Holdings completes Catalent acquisition for $16.5bn" was originally created ...

Novo Nordisk has taken the bold step of buying three manufacturing facilities from contract development and manufacturing organisation Catalent as it tries to meet surging demand for its diabetes ...

Meagher & Flom LLP act as legal advisors to Catalent. Morgan Stanley and Goodwin Procter LLP are advisers to Novo Holdings. Novo Holdings is an asset management holding and investment company of the ...

Novo Holdings’ $16.5 billion takeover of US contract development and manufacturing organisation (CDMO) Catalent does not create competition issues and can go ahead, according to the European ...

Morgan Stanley initiated coverage of Novo Nordisk (NVO) with an Equal Weight rating and DKK 700 price target The firm says near-term U.S. obesity market dynamics remain uncertain. Novo’s ...

Novo Nordisk also reported the acquisition of three manufacturing sites from Novo Holdings A/S following the finalization of Novo Holdings' acquisition of Catalent, Inc. - a global contract ...

Morgan Stanley began coverage on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a research report released on Wednesday morning, Marketbeat.com reports. The firm issued an equal weight ...

Novo Nordisk also reinforced its leadership in the GLP-1 market, maintaining its dominant position with nearly two-thirds of all GLP-1 patients using its treatments. A key milestone for the company ...

Morgan Stanley (MS) initiated equal weight coverage on healthcare company Novo Nordisk (NVO), citing the potential in the global obesity market. While Novo's stock dropped slightly, the firm sees ...